Near-term prognostic impact of integrated muscle mass and function in upper gastrointestinal cancer

Clin Nutr. 2021 Sep;40(9):5169-5179. doi: 10.1016/j.clnu.2021.07.028. Epub 2021 Jul 31.

Abstract

Background: Despite the known association between muscle mass/function and malnutrition-related mortality in upper gastrointestinal (UGI) cancer, no comprehensive study to determine the impact of muscle mass-dominant nutritional status on cancer prognosis has been conducted. The present study aimed to investigate the prognostic significance of integrated muscle mass and function in UGI cancer.

Methods: Between July 2013 and March 2018, we enrolled 2546 cancer patients with risks of malnutrition (Nutrition Risk Screening 2002, ≥3 points) from a multicenter cohort study and split 527 patients with primary UGI cancer into an internal validation group. We prospectively performed instant nutritional assessment and recorded all general clinical characteristics of the participants, such as weight loss, body mass index, anthropometric measurements of muscle mass and function, dietary intake conditions, and disease burden and/or inflammation status based on the validated tools. Prognostic analyses were performed with post-assessment overall survival (OS).

Results: According to the entire set, UGI cancer was identified as the dominant risk factor for disease burden and inflammation criteria (hazard ratio (HR), 2.08, 95% confidence interval (Cl), 1.81-2.39, P < 0.001). Integrated muscle mass/function analysis with validated cutoff values showed that hand grip strength/weight followed by triceps skinfold thickness and maximum calf circumference are the most potent predictors. Univariate and multivariate analyses revealed that reduced muscle mass/function (74.8%) and dietary intake (66.2%) independently affect OS of patients with UGI cancer. Significant associations were found between the reduced muscle mass/reduced dietary intake and the shortest OS (HR, 4.48; 95% Cl, 3.07-6.53; P < 0.001). Appending subgroups of muscle mass/function and dietary intake to the pre-existing risk model increased the efficiency of the time-dependent receiver operating characteristic curve analysis for OS in UGI cancer, particularly within 2 years of instant nutritional assessment.

Conclusion: Impaired muscle mass/function adversely affects the near-term prognosis in patients with UGI cancer. Along with a comprehensive evaluation of dietary intake conditions, the timely nutritional assessment might be useful for risk stratification of UGI cancers with potential for enteral and parenteral nutrition interventions.

Registration number: ChiCTR1800020329.

Keywords: Eating; Malnutrition; Muscle mass/function; Prognosis; Upper gastrointestinal cancer.

Publication types

  • Multicenter Study
  • Observational Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Anthropometry
  • Body Mass Index
  • Eating
  • Female
  • Gastrointestinal Neoplasms / complications
  • Gastrointestinal Neoplasms / mortality*
  • Gastrointestinal Neoplasms / physiopathology
  • Hand Strength
  • Humans
  • Male
  • Malnutrition / diagnosis
  • Malnutrition / etiology
  • Malnutrition / mortality*
  • Middle Aged
  • Muscle, Skeletal / physiopathology
  • Nutrition Assessment*
  • Nutritional Status
  • Prognosis
  • Proportional Hazards Models
  • Prospective Studies
  • Risk Assessment*
  • Risk Factors
  • Sarcopenia / diagnosis
  • Sarcopenia / etiology
  • Sarcopenia / mortality*
  • Skinfold Thickness
  • Weight Loss

Associated data

  • ChiCTR/ChiCTR1800020329